1. A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma. Issue 10 (26th August 2020) Authors: Kudo, Masatoshi; Morimoto, Manabu; Moriguchi, Michihisa; Izumi, Namiki; Takayama, Tetsuji; Yoshiji, Hitoshi; Hino, Keisuke; Oikawa, Takayoshi; Chiba, Tetsuhiro; Motomura, Kenta; Kato, Junko; Yasuchika, Kentaro; Ido, Akio; Sato, Takashi; Nakashima, Daisuke; Ueshima, Kazuomi; Ikeda, Masafumi; Okusa... Journal: Cancer science Issue: Volume 111:Issue 10(2020) Page Start: 3759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment for retreatment (ART) score for repeated transarterial chemoembolization in patients with hepatocellular carcinoma. Issue 6 (28th April 2014) Authors: Kudo, Masatoshi; Arizumi, Tadaaki; Ueshima, Kazuomi Journal: Hepatology Issue: Volume 59:Issue 6(2014:Jun.) Page Start: 2424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical implication of immune checkpoint inhibitor on the chronic hepatitis B virus infection. Issue 9 (15th June 2022) Authors: Hagiwara, Satoru; Nishida, Naoshi; Ida, Hiroshi; Ueshima, Kazuomi; Minami, Yasunori; Takita, Masahiro; Aoki, Tomoko; Morita, Masahiro; Chishina, Hirokazu; Komeda, Yoriaki; Yoshida, Akihiro; Hayashi, Hidetoshi; Nakagawa, Kazuhiko; Kudo, Masatoshi Journal: Hepatology research Issue: Volume 52:Issue 9(2022) Page Start: 754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines). Issue 5 (10th March 2023) Authors: Hasegawa, Kiyoshi; Takemura, Nobuyuki; Yamashita, Tatsuya; Watadani, Takeyuki; Kaibori, Masaki; Kubo, Shoji; Shimada, Mitsuo; Nagano, Hiroaki; Hatano, Etsuro; Aikata, Hiroshi; Iijima, Hiroko; Ueshima, Kazuomi; Ohkawa, Kazuyoshi; Genda, Takuya; Tsuchiya, Kaoru; Torimura, Takuji; Ikeda, Masafumi; F... Journal: Hepatology research Issue: Volume 53:Issue 5(2023) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cold‐inducible RNA‐binding protein promotes the development of liver cancer. Issue 4 (3rd March 2015) Authors: Sakurai, Toshiharu; Yada, Norihisa; Watanabe, Tomohiro; Arizumi, Tadaaki; Hagiwara, Satoru; Ueshima, Kazuomi; Nishida, Naoshi; Fujita, Jun; Kudo, Masatoshi Journal: Cancer science Issue: Volume 106:Issue 4(2015:Apr.) Page Start: 352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparison of efficacy and safety of entecavir and switching from entecavir to tenofovir alafenamide fumarate in chronic hepatitis B: Long‐term effects from a prospective study. Issue 7 (7th May 2021) Authors: Hagiwara, Satoru; Nishida, Naoshi; Ueshima, Kazuomi; Yoshida, Akihiro; Minami, Yasunori; Kudo, Masatoshi Journal: Hepatology research Issue: Volume 51:Issue 7(2021) Page Start: 767 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma1. Issue 4 (11th February 2013) Authors: Arao, Tokuzo; Ueshima, Kazuomi; Matsumoto, Kazuko; Nagai, Tomoyuki; Kimura, Hideharu; Hagiwara, Satoru; Sakurai, Toshiharu; Haji, Seiji; Kanazawa, Akishige; Hidaka, Hisashi; Iso, Yukihiro; Kubota, Keiichi; Shimada, Mitsuo; Utsunomiya, Tohru; Hirooka, Masashi; Hiasa, Yoichi; Toyoki, Yoshikazu; Hak... Journal: Hepatology Issue: Volume 57:Issue 4(2013:Apr.) Page Start: 1407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi‐institutional propensity‐matched cohort study. (15th September 2022) Authors: Komatsu, Shohei; Ueshima, Kazuomi; Kido, Masahiro; Kuramitsu, Kaori; Tsugawa, Daisuke; Yanagimoto, Hiroaki; Toyama, Hirochika; Ku, Yonon; Kudo, Masatoshi; Fukumoto, Takumi Journal: Journal of hepato-biliary-pancreatic sciences Issue: Volume 30:Number 3(2023) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of peginterferon alpha‐2b and entecavir hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis B. Issue 6 (12th April 2013) Authors: Hagiwara, Satoru; Kudo, Masatoshi; Osaki, Yukio; Matsuo, Hiroo; Inuzuka, Tadashi; Matsumoto, Akihiro; Tanaka, Eiji; Sakurai, Toshiharu; Ueshima, Kazuomi; Inoue, Tatsuo; Yada, Norihisa; Nishida, Naoshi Journal: Journal of medical virology Issue: Volume 85:Issue 6(2013:Jun.) Page Start: 987 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of peginterferon alpha‐2b and entecavir hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis B1. Issue 6 (12th April 2013) Authors: Hagiwara, Satoru; Kudo, Masatoshi; Osaki, Yukio; Matsuo, Hiroo; Inuzuka, Tadashi; Matsumoto, Akihiro; Tanaka, Eiji; Sakurai, Toshiharu; Ueshima, Kazuomi; Inoue, Tatsuo; Yada, Norihisa; Nishida, Naoshi Journal: Journal of medical virology Issue: Volume 85:Issue 6(2013:Jun.) Page Start: 987 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗